Gene · 8794
Papers1,743
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,743
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3+CD8+CD56+ Natural Killer T Population in Women with Recurrent Spontaneous Abortion. | J Hum Reprod Sci | 2023 | 38045499 | PubTator, text mining | PubMed |
| Molluscan Genomes Reveal Extensive Differences in Photopigment Evolution Across the Phylum. | Mol Biol Evol | 2023 | 38039155 | PubTator, text mining | PubMed |
| From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning. | Mil Med Res | 2023 | 38017571 | PubTator, text mining | PubMed |
| The Role and Therapeutic Implications of Inflammation in the Pathogenesis of Brain Arteriovenous Malformations. | Biomedicines | 2023 | 38001877 | PubTator, text mining | PubMed |
| Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective. | Cancers (Basel) | 2023 | 38001653 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Microvesicles from Adipose Tissue: Unraveling Their Impact on Primary Ovarian Cancer Cells and Their Therapeutic Opportunities. | Int J Mol Sci | 2023 | 37958844 | PubTator, text mining | PubMed |
| Subtyping of COVID-19 samples based on cell-cell interaction in single cell transcriptomes. | Sci Rep | 2023 | 37949890 | PubTator, text mining | PubMed |
Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression. | Int J Mol Sci | 2023 | 37894764 | PubTator, text mining | PubMed |
| Trypanosoma cruzi STIB980: A TcI Strain for Drug Discovery and Reverse Genetics. | Pathogens | 2023 | 37887733 | PubTator, text mining | PubMed |
| Death receptor 5 promotes tumor progression in gastric cancer. | FEBS Open Bio | 2023 | 37879960 | PubTator, text mining | PubMed |
| Generation of magnetic biohybrid microrobots based on MSC.sTRAIL for targeted stem cell delivery and treatment of cancer. | Cancer Nanotechnol | 2023 | 37869575 | PubTator, text mining | PubMed |
| An Antidepressant Drug Increased TRAIL Receptor-2 Expression and Sensitized Lung Cancer Cells to TRAIL-induced Apoptosis. | Anticancer Agents Med Chem | 2023 | 37859313 | PubTator, text mining | PubMed |
The tumor suppressive effect and apoptotic mechanism of TRAIL gene-containing recombinant NDV in TRAIL-resistant colorectal cancer HT-29 cells and TRAIL-nonresistant HCT116 cells, with each cell bearing a mouse model. | Cancer Med | 2023 | 37843231 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content. | Front Immunol | 2023 | 37809073 | PubTator, text mining | PubMed |
| Supra-second interval timing in bipolar disorder: examining the role of disorder sub-type, mood, and medication status. | Int J Bipolar Disord | 2023 | 37779127 | PubTator, text mining | PubMed |
| Bioinformatics analysis of copper death gene in diabetic immune infiltration. | Medicine (Baltimore) | 2023 | 37773841 | PubTator, text mining | PubMed |
| Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension. | ESC Heart Fail | 2023 | 37772417 | PubTator, text mining | PubMed |
| Emerging Role of Decoy Receptor-2 as a Cancer Risk Predictor in Oral Potentially Malignant Disorders. | Int J Mol Sci | 2023 | 37762685 | PubTator, text mining | PubMed |
| High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer. | Int J Mol Sci | 2023 | 37761986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8794/papers?page=5